{"id":"NCT02668692","sponsor":"LEO Pharma","briefTitle":"LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis","officialTitle":"Efficacy and Safety of LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02","primaryCompletion":"2016-06","completion":"2016-06","firstPosted":"2016-01-29","resultsPosted":"2021-07-27","lastUpdate":"2025-03-10"},"enrollment":213,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis Vulgaris"],"interventions":[{"type":"DRUG","name":"LEO 80185 gel","otherNames":[]},{"type":"DRUG","name":"Dovobet 速 ointment","otherNames":[]}],"arms":[{"label":"LEO 80185 gel","type":"EXPERIMENTAL"},{"label":"Dovobet 速 ointment","type":"ACTIVE_COMPARATOR"}],"summary":"To compare the efficacy and safety of LEO 80185 gel with Dovobet速 ointment in the treatment of psoriasis in Japanese subjects.","primaryOutcome":{"measure":"Number of Subjects With 'Overall Improvement' for the Target Lesion on the Scalp","timeFrame":"End of Week 4","effectByArm":[{"arm":"LEO 80185 Gel","deltaMin":99,"sd":null},{"arm":"Dovobet速 Ointment","deltaMin":101,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.68"},{"comp":"OG000 vs OG001","p":"=0.68"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":19},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://www.leopharmatrials.com/en"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":101},"commonTop":["Nasopharyngitis","Folliculitis","Anaemia","Glucose urine present","Leukocytosis"]}}